SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Eva Cernuda-Morollón, César Ramón, Pablo Martínez-Camblor, Esther Serrano-Pertierra, Davinia Larrosa, Julio Pascual, OnabotulinumtoxinA decreases interictal CGRP plasma levels in patients with chronic migraine, PAIN, 2015, 156, 5, 820

    CrossRef

  2. 2
    Ki Yeon Yoo, Hee Su Lee, Young Kyung Cho, You Sun Lim, Yi Seul Kim, Jung Hoi Koo, Se Jin Yoon, Jung Hwan Lee, Ki Hyo Jang, Sun Hong Song, Anti-inflammatory Effects of Botulinum Toxin Type A in a Complete Freund’s Adjuvant-Induced Arthritic Knee Joint of Hind Leg on Rat Model, Neurotoxicity Research, 2014, 26, 1, 32

    CrossRef

  3. 3
    Scott M. Whitcup, Catherine C. Turkel, Ronald E. DeGryse, Mitchell F. Brin, Development of onabotulinumtoxinA for chronic migraine, Annals of the New York Academy of Sciences, 2014, 1329, 1
  4. 4
    Kayi Chan, Antoinette MaassenVanDenBrink, Glutamate Receptor Antagonists in the Management of Migraine, Drugs, 2014, 74, 11, 1165

    CrossRef

  5. 5
    Aziz Khambati, Susan Lau, Allan Gordon, Keith A. Jarvi, OnabotulinumtoxinA (Botox) Nerve Blocks Provide Durable Pain Relief for Men with Chronic Scrotal Pain: A Pilot Open-Label Trial, The Journal of Sexual Medicine, 2014, 11, 12
  6. 6
    H.-C. Diener, D. W. Dodick, C. C. Turkel, G. Demos, R. E. DeGryse, N. L. Earl, M. F. Brin, Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine, European Journal of Neurology, 2014, 21, 6
  7. 7
    Cristian Sager, Carol Burek, Juan Bortagaray, Juan Pablo Corbetta, Santiago Weller, Victor Durán, Juan Carlos Lopez, Repeated injections of intradetrusor onabotulinumtoxinA as adjunctive treatment of children with neurogenic bladder, Pediatric Surgery International, 2014, 30, 1, 79

    CrossRef

  8. 8
    Lizu Xiao, Jianguo Cheng, Yu Zhuang, Wenchun Qu, Jeffery Muir, Haowen Liang, Deren Zhang, Botulinum Toxin Type A Reduces Hyperalgesia and TRPV1 Expression in Rats with Neuropathic Pain, Pain Medicine, 2013, 14, 2
  9. 9
    Yu-Feng Shao, Yi Zhang, Peng Zhao, Wen-Jun Yan, Xiang-Pan Kong, Lin-Lan Fan, Yi-Ping Hou, Botulinum Toxin Type A Therapy in Migraine: Preclinical and Clinical Trials, Iranian Red Crescent Medical Journal, 2013, 15, 10

    CrossRef

  10. 10
    Irina Soljanik, Efficacy and Safety of Botulinum Toxin A Intradetrusor Injections in Adults with Neurogenic Detrusor Overactivity/Neurogenic Overactive Bladder: A Systematic Review, Drugs, 2013, 73, 10, 1055

    CrossRef

  11. 11
    Avi Ashkenazi, Andrew Blumenfeld, OnabotulinumtoxinA for the Treatment of Headache, Headache: The Journal of Head and Face Pain, 2013, 53,
  12. 12
    Paul L. Durham, Caleb G. Masterson, Two Mechanisms Involved in Trigeminal CGRP Release: Implications for Migraine Treatment, Headache: The Journal of Head and Face Pain, 2013, 53, 1
  13. 13
    Sudha Balakrishnan, Anthony B. Ward, Neurological Rehabilitation, 2013,

    CrossRef

  14. 14
    Hong Wu, Rizwana Sultana, Kerrey Barton Taylor, Aniko Szabo, A Prospective Randomized Double-blinded Pilot Study to Examine the Effect of Botulinum Toxin Type A Injection Versus Lidocaine/Depomedrol Injection on Residual and Phantom Limb Pain, The Clinical Journal of Pain, 2012, 28, 2, 108

    CrossRef

  15. 15
    Douglas G. Tincello, Botulinum toxin treatment for overactive bladder and detrusor overactivity in adults, World Journal of Urology, 2012, 30, 4, 451

    CrossRef

  16. 16
    H. Schulte-Baukloh, Botulinumtoxin bei neurogener Blasenfunktionsstörung, Der Urologe, 2012, 51, 2, 198

    CrossRef

  17. 17
    Alessandro Clemenzi, Rita Formisano, Maria Matteis, Luciano Gallinacci, Giulio Cochi, Paola Savina, Paola Cicinelli, Care management of spasticity with botulinum toxin-A in patients with severe acquired brain injury: A 1-year follow-up prospective study, Brain Injury, 2012, 26, 7-8, 979

    CrossRef

  18. 18
    Antonio Marte, Onabotulinumtoxin A for Treating Overactive/Poor Compliant Bladders in Children and Adolescents with Neurogenic Bladder Secondary to Myelomeningocele, Toxins, 2012, 5, 1, 16

    CrossRef

  19. 19
    Stuart A. Yablon, Mitchell F. Brin, Amanda M. VanDenburgh, Jihao Zhou, Susan M. Garabedian-Ruffalo, Susan Abu-Shakra, Frederick C. Beddingfield, Dose response with onabotulinumtoxinA for post-stroke spasticity: A pooled data analysis, Movement Disorders, 2011, 26, 2
  20. 20
    Paul L. Durham, Roger Cady, Insights Into the Mechanism of OnabotulinumtoxinA in Chronic Migraine, Headache: The Journal of Head and Face Pain, 2011, 51, 10
  21. 21
    Alexander G. Rabchevsky, Patrick H. Kitzman, Latest Approaches for the Treatment of Spasticity and Autonomic Dysreflexia in Chronic Spinal Cord Injury, Neurotherapeutics, 2011, 8, 2, 274

    CrossRef

  22. 22
    Theodore A. Kung, Bahman Guyuron, Paul S. Cederna, Migraine Surgery: A Plastic Surgery Solution for Refractory Migraine Headache, Plastic and Reconstructive Surgery, 2011, 127, 1, 181

    CrossRef

  23. 23
    E Natalie Ravid, Liu Shi Gan, Kathryn Todd, Arthur Prochazka, Nerve lesioning with direct current, Journal of Neural Engineering, 2011, 8, 1, 016005

    CrossRef

  24. 24
    Apostolos Apostolidis, Pharmacotherapy for overactive bladder: minimally invasive treatment – botulinum toxins, Expert Opinion on Pharmacotherapy, 2011, 12, 7, 1029

    CrossRef

  25. 25
    Eigild Møller, Merete Karlsborg, Allan Bardow, Joan Lykkeaa, Flemming H. Nissen, Merete Bakke, Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: Efficacy and possible mechanisms, Acta Odontologica Scandinavica, 2011, 69, 3, 151

    CrossRef

  26. 26
    Francis O. Walker, Neuromuscular Ultrasound, 2011,

    CrossRef

  27. 27
    Athanassios Oeconomou, Apostolos Apostolidis, Current Status of Botulinum Toxin for Neurogenic Bladder Dysfunction, Current Bladder Dysfunction Reports, 2010, 5, 2, 87

    CrossRef

  28. 28
    Baskaran Thyagarajan, Joseph G. Potian, Carmen C. Garcia, Kormakur Hognason, Kateřina Čapková, Scott T. Moe, Alan R. Jacobson, Kim D. Janda, Joseph J. McArdle, Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions, Neuropharmacology, 2010, 58, 8, 1189

    CrossRef

  29. You have free access to this content29
    David W. Dodick, Catherine C. Turkel, Ronald E. DeGryse, Sheena K. Aurora, Stephen D. Silberstein, Richard B. Lipton, Hans-Christoph Diener, Mitchell F. Brin, OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program, Headache: The Journal of Head and Face Pain, 2010, 50, 6
  30. 30
    Paul J. Christo, Dana K. Christo, Adam J. Carinci, Julie A. Freischlag, Single CT-Guided Chemodenervation of the Anterior Scalene Muscle with Botulinum Toxin for Neurogenic Thoracic Outlet Syndrome, Pain Medicine, 2010, 11, 4
  31. 31
    Alexander Mauskop, Headache, 2010,

    CrossRef

  32. 32
    R. Norman Harden, Jerod Cottrill, Christine M. Gagnon, Todd A. Smitherman, Stephan R. Weinland, Beverley Tann, Petra Joseph, Thomas S. Lee, Timothy T. Houle, Botulinum Toxin A in the Treatment of Chronic Tension-Type Headache With Cervical Myofascial Trigger Points: A Randomized, Double-Blind, Placebo-Controlled Pilot Study, Headache: The Journal of Head and Face Pain, 2009, 49, 5
  33. 33
    Avi Ashkenazi, Stephen Silberstein, Is botulinum toxin useful in treating headache? Yes, Current Treatment Options in Neurology, 2009, 11, 1, 18

    CrossRef

  34. 34
    Ninaad S. Awsare, David R. Jones, Paraplegia as a complication of intravesical Botulinum toxin A (Dysport®) injection for overactive bladder, British Journal of Medical and Surgical Urology, 2009, 2, 3, 127

    CrossRef

  35. 35
    Apostolos Apostolidis, Prokar Dasgupta, Pierre Denys, Sohier Elneil, Clare J. Fowler, Antonella Giannantoni, Gilles Karsenty, Heinrich Schulte-Baukloh, Brigitte Schurch, Jean-Jacques Wyndaele, Recommendations on the Use of Botulinum Toxin in the Treatment of Lower Urinary Tract Disorders and Pelvic Floor Dysfunctions: A European Consensus Report, European Urology, 2009, 55, 1, 100

    CrossRef

  36. 36
    Martin K. Childers, Botulinum Toxin, 2009,

    CrossRef

  37. 37
    Andrew M. Blumenfeld, Jack D. Schim, Thomas J. Chippendale, Botulinum Toxin Type A and Divalproex Sodium for Prophylactic Treatment of Episodic or Chronic Migraine, Headache: The Journal of Head and Face Pain, 2008, 48, 2
  38. 38
    Roger Cady, Curtis Schreiber, Botulinum Toxin Type A as Migraine Preventive Treatment in Patients Previously Failing Oral Prophylactic Treatment Due To Compliance Issues, Headache: The Journal of Head and Face Pain, 2008, 48, 6
  39. 39
    Ninan T. Mathew, Jayasree Kailasam, Lori Meadors, Botulinum Toxin Type A for the Treatment of Nummular Headache: Four Case Studies, Headache: The Journal of Head and Face Pain, 2008, 48, 3
  40. 40
    Allison Brashear, Clinical Comparisons of Botulinum Neurotoxin Formulations, The Neurologist, 2008, 14, 5, 289

    CrossRef

  41. 41
    Shashank J. Dave, Pilocarpine for the Treatment of Refractory Dry Mouth (Xerostomia) Associated with Botulinum Toxin Type B, American Journal of Physical Medicine & Rehabilitation, 2008, 87, 8, 684

    CrossRef

  42. 42
    A. B. Ward, Spasticity treatment with botulinum toxins, Journal of Neural Transmission, 2008, 115, 4, 607

    CrossRef

  43. 43
    A. Apostolidis, C. J. Fowler, The use of botulinum neurotoxin type A (BoNTA) in urology, Journal of Neural Transmission, 2008, 115, 4, 593

    CrossRef

  44. 44
    Hsin-Min Lee, Jia-Jin Jason Chen, Yi-Ning Wu, Yu-Lin Wang, Sheng-Chih Huang, Maria Piotrkiewicz, Time Course Analysis of the Effects of Botulinum Toxin Type A on Elbow Spasticity Based on Biomechanic and Electromyographic Parameters, Archives of Physical Medicine and Rehabilitation, 2008, 89, 4, 692

    CrossRef

  45. 45
    M Relja, AC Poole, J Schoenen, J Pascual, X Lei, C Thompson, A multicentre, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of episodic migraine headaches, Cephalalgia, 2007, 27, 6
  46. You have free access to this content46
    Sheena K. Aurora, Marek Gawel, Jan L. Brandes, Suriani Pokta, Amanda M. VanDenburgh, Botulinum Toxin Type A Prophylactic Treatment of Episodic Migraine: A Randomized, Double-Blind, Placebo-Controlled Exploratory Study, Headache: The Journal of Head and Face Pain, 2007, 47, 4
  47. 47
    Franci Stavropoulos, Barbara A. Hastie, Chronic Facial Pain in the Female Patient: Treatment Updates, Oral and Maxillofacial Surgery Clinics of North America, 2007, 19, 2, 245

    CrossRef

  48. 48
    R. Wenzel, D. Jones, J. A. Borrego, Comparing two botulinum toxin type A formulations using manufacturers’ product summaries, Journal of Clinical Pharmacy and Therapeutics, 2007, 32, 4
  49. 49
    Stuart A. Yablon, Allison Brashear, Mark F. Gordon, Elie P. Elovic, Catherine C. Turkel, Simon Daggett, Jingyu Liu, Mitchell F. Brin, Formation of neutralizing antibodies in patients receiving botulinum toxin type a for treatment of poststroke spasticity: A pooled-data analysis of three clinical trials, Clinical Therapeutics, 2007, 29, 4, 683

    CrossRef

  50. 50
    Marcela Romero-Reyes, Steven Graff-Radford, Is There Hope for Chronic Pain and Headache?, Headache: The Journal of Head and Face Pain, 2007, 47, 8
  51. 51
    Mhorag E.A. Duff, Richard E. Morton, Managing spasticity in children, Paediatrics and Child Health, 2007, 17, 12, 463

    CrossRef

  52. 52
    D J John Park, Andrew R Harrison, Oculoplastic applications of botulinum toxin, Expert Review of Ophthalmology, 2007, 2, 4, 571

    CrossRef

  53. 53
    Miguel J.A. Láinez, Anna Piera, Tinnitus: Pathophysiology and Treatment, 2007,

    CrossRef

  54. 54
    M Volcy, SJ Tepper, AM Rapoport, FD Sheftell, ME Bigal, Botulinum toxin A for the treatment of greater occipital neuralgia and trigeminal neuralgia: a case report with pathophysiological considerations, Cephalalgia, 2006, 26, 3
  55. 55
    Sheena Aurora, Botulinum toxin type A for the treatment of migraine, Expert Opinion on Pharmacotherapy, 2006, 7, 8, 1085

    CrossRef

  56. 56
    SD Silberstein, H Göbel, R Jensen, AH Elkind, R DeGryse, JMCM Walcott, C Turkel, Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study, Cephalalgia, 2006, 26, 7
  57. 57
    Vinod Kumar Gupta, Botulinum Toxin—A Treatment for Migraine? A Systematic Review, Pain Medicine, 2006, 7, 5
  58. 58
    Moshe Jakubowski, Peter J. McAllister, Zahid H. Bajwa, Thomas N. Ward, Patty Smith, Rami Burstein, Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A, Pain, 2006, 125, 3, 286

    CrossRef

  59. 59
    Maren L. Mahowald, Jasvinder A. Singh, Dennis Dykstra, Long term effects of intra-articular botulinum toxin a for refractory joint pain, Neurotoxicity Research, 2006, 9, 2-3, 179

    CrossRef

  60. 60
    Ninan T. Mathew, The Prophylactic Treatment of Chronic Daily Headache, Headache: The Journal of Head and Face Pain, 2006, 46, 10
  61. 61
    J. O. Dolly, K. R. Aoki, The structure and mode of action of different botulinum toxins, European Journal of Neurology, 2006, 13,
  62. 62
    Susan R. Criswell, Beth E. Crowner, Brad A. Racette, The use of botulinum toxin therapy for lower-extremity spasticity in children with cerebral palsy, Neurosurgical FOCUS, 2006, 21, 2, 1

    CrossRef

  63. 63
    Apostolos Apostolidis, Axel Haferkamp, K. Roger Aoki, Understanding the Role of Botulinum Toxin A in the Treatment of the Overactive Bladder—More than Just Muscle Relaxation, European Urology Supplements, 2006, 5, 11, 670

    CrossRef

  64. 64
    ROSHNI POPAT, APOSTOLOS APOSTOLIDIS, VINAY KALSI, GWENDOLINE GONZALES, CLARE J. FOWLER, PROKAR DASGUPTA, A COMPARISON BETWEEN THE RESPONSE OF PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY AND NEUROGENIC DETRUSOR OVERACTIVITY TO THE FIRST INTRADETRUSOR INJECTION OF BOTULINUM-A TOXIN, The Journal of Urology, 2005, 174, 3, 984

    CrossRef

  65. 65
    Keith A. Foster, A new wrinkle on pain relief: re-engineering clostridial neurotoxins for analgesics, Drug Discovery Today, 2005, 10, 8, 563

    CrossRef

  66. 66
    Ninan T. Mathew, Benjamin M. Frishberg, Marek Gawel, Rozalina Dimitrova, John Gibson, Catherine Turkel, Botulinum Toxin Type A (BOTOX®) for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double-Blind, Placebo-Controlled Trial, Headache: The Journal of Head and Face Pain, 2005, 45, 4
  67. 67
    Stephen D. Silberstein, Stuart R. Stark, Sylvia M. Lucas, Suzanne N. Christie, Ronald E. Degryse, Catherine C. Turkel, Botulinum Toxin Type A for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double-Blind, Placebo-Controlled Trial, Mayo Clinic Proceedings, 2005, 80, 9, 1126

    CrossRef

  68. You have free access to this content68
    David W. Dodick, Alexander Mauskop, Arthur H. Elkind, Ronald DeGryse, Mitchell F. Brin, Stephen D. Silberstein, Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications: A Randomized Double-Blind, Placebo-Controlled Study, Headache: The Journal of Head and Face Pain, 2005, 45, 4
  69. 69
    B SCHURCH, M DESEZE, P DENYS, E CHARTIERKASTLER, F HAAB, K EVERAERT, P PLANTE, B PERROUINVERBE, C KUMAR, S FRACZEK, BOTULINUM TOXIN TYPE A IS A SAFE AND EFFECTIVE TREATMENT FOR NEUROGENIC URINARY INCONTINENCE: RESULTS OF A SINGLE TREATMENT, RANDOMIZED, PLACEBO CONTROLLED 6-MONTH STUDY, The Journal of Urology, 2005, 174, 1, 196

    CrossRef

  70. 70
    James C. Burnett, James J. Schmidt, Connor F. McGrath, Tam L. Nguyen, Ann R. Hermone, Rekha G. Panchal, Jonathan L. Vennerstrom, Krishna Kodukula, Daniel W. Zaharevitz, Rick Gussio, Sina Bavari, Conformational sampling of the botulinum neurotoxin serotype a light chain: implications for inhibitor binding, Bioorganic & Medicinal Chemistry, 2005, 13, 2, 333

    CrossRef

  71. 71
    Eric J. Eross, Jonathan P. Gladstone, Susan Lewis, Robert Rogers, David W. Dodick, Duration of Migraine Is a Predictor for Response to Botulinum Toxin Type A, Headache: The Journal of Head and Face Pain, 2005, 45, 4
  72. 72
    Cynthia L. Comella, Lance L. Simpson, Joseph Jankovic, From Neuroscience To Neurology, 2005,

    CrossRef

  73. 73
    B Todd Troost, Botulinum toxin type A (Botox®) in the treatment of migraine and other headaches, Expert Review of Neurotherapeutics, 2004, 4, 1, 27

    CrossRef

  74. 74
    Andrew Blumenfeld, Botulinum Toxin Type A for the Treatment of Headache: Pro, Headache: The Journal of Head and Face Pain, 2004, 44, 8
  75. 75
    G.N Rajkumar, I.G Conn, Botulinum toxin: a new dimension in the treatment of lower urinary tract dysfunction, Urology, 2004, 64, 1, 2

    CrossRef

  76. 76
    Martin K Childers, Allison Brashear, Patricia Jozefczyk, Michael Reding, David Alexander, David Good, Jennifer M Walcott, S.W Jenkins, Catherine Turkel, Patricia T Molloy, Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke, Archives of Physical Medicine and Rehabilitation, 2004, 85, 7, 1063

    CrossRef

  77. 77
    Thomas M Buchanan, Nabih M Ramadan, Sheena Aurora, Future pharmacologic targets for acute and preventive treatments of migraine, Expert Review of Neurotherapeutics, 2004, 4, 3, 391

    CrossRef

  78. 78
    Johan A. Smuts, Donovan Schultz, Adri Barnard, Mechanism of Action of Botulinum Toxin Type A in Migraine Prevention: A Pilot Study, Headache: The Journal of Head and Face Pain, 2004, 44, 8
  79. You have free access to this content79
    Paul L. Durham, Ryan Cady, Roger Cady, Regulation of Calcitonin Gene-Related Peptide Secretion From Trigeminal Nerve Cells by Botulinum Toxin Type A: Implications for Migraine Therapy, Headache: The Journal of Head and Face Pain, 2004, 44, 1
  80. 80
    Keith A Foster, The analgesic potential of clostridial neurotoxin derivatives, Expert Opinion on Investigational Drugs, 2004, 13, 11, 1437

    CrossRef

  81. 81
    S. Raj Sundaraj, Paul Ponciano, Charlotte Johnstone, Faiz Noore, Maria Castro, Treatment of Chronic Refractory Intractable Headache with Botulinum Toxin Type A: A Retrospective Study, Pain Practice, 2004, 4, 3